bpc-157 with tb500 BPC-157/TB-500 Capsules BPC 157 and TB 500

caution in methylation disorders (use only under supervision) No known drug interactions with oral medications, but B12 may mask B9 (folate) deficiencycombined B-vitamin status should be assessed periodically

While the peptides lack of IGF-1 effects and glucose impact suggests minimal interaction potential, comprehensive medication review remains appropriate, particularly for drugs affecting metabolism or blood glucose

Property Detail Full Name Body Protection Compound 157 Amino Acids 15 (pentadecapeptide) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1,419 g/mol Forms reviewed by FDA Free base and acetate salt FDA Status Not approved Active IND applications None (as of April 2026) Compounding status Under reclassification review (July 23-24, 2026) Is BPC-157 FDA Approved in 2026

The result is a 23.3 mg/mL total-blend concentration

Then convert mL to units: multiply mL by 100 (on a U-100 syringe)